Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC
- Conditions
- Progressive Familial Intrahepatic Cholestasis
- Interventions
- Drug: A4250 (odevixibat)
- Registration Number
- NCT03659916
- Lead Sponsor
- Albireo, an Ipsen Company
- Brief Summary
Open Label Extension Study to evaluate long term safety and persistence of effect of A4250 in children with PFIC.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 116
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description A4250 A4250 (odevixibat) Capsules for oral administration (40 or 120 ยตg/kg) once daily for 72 weeks, or 40 ยตg/kg/day for the first 12 weeks followed by 120 ยตg/kg/day for the remaining 60 weeks"
- Primary Outcome Measures
Name Time Method US: Change in Pruritus From baseline over 72 weeks Change in pruritus as indexed by caregiver-reported (Albireo ObsRO instrument) observed scratching
EU and rest of world: Change in serum bile acids From baseline up to week 72
- Secondary Outcome Measures
Name Time Method All regions. All-cause mortality From baseline to weeks 24, 48, and 72 EU and rest of world: Proportion of positive pruritus assessments at the patient level over the 72-week treatment period using the Albireo ObsRO instrument. 72 weeks US: Change from baseline in serum bile acids after 72 weeks of treatment. 72 weeks All regions: Proportion of individual assessments meeting the definition of a positive pruritus assessment at the patient level using the Albireo ObsRO instrument. weeks 0-4, 0-12, 0-22, 0-24, 0-36, 0-46, 0-48, 0-60, 0-70, or the proportion of positive pruritus assessments at each 4-week interval between V1/Screening and V5/Week 24, then by each visit between V5/Week 24 to V12/Week 76 All regions: Proportion of individual PM assessments meeting the definition of a positive pruritus assessment at the patient level using the Albireo ObsRO instrument weeks 0-4, 0-12, 0-22, 0-24, 0-36, 0-46, 0-48, 0-60, 0-70, or the proportion of positive pruritus assessments at each 4-week interval between V1/Screening and V5/Week 24, then by each visit between V5/Week 24 to V12/Week 76 All regions: Number of patients undergoing biliary diversion surgery From baseline to weeks 24, 48, and 72 All regions: Number of patients undergoing liver transplantation From baseline to weeks 24, 48, and 72 All regions: Change in growth From baseline to weeks 24, 48, and 72 The linear growth deficit compared to the standard growth curve
All regions: Change in AST to platelet ratio idex (APRI) score From baseline to week 72 All regions: 3. Change from baseline in serum bile acids at Weeks 4, 12, 22, 24, 36, 46, 48, 60, 70, 72, and 76 Weeks 4, 12, 22, 24, 36, 46, 48, 60, 70, 72, and 76 All regions: Proportion of individual AM assessments meeting the definition of a positive pruritus assessment at the patient level using the Albireo ObsRO instrument weeks 0-4, 0-12, 0-22, 0-24, 0-36, 0-46, 0-48, 0-60, 0-70, or the proportion of positive pruritus assessments at each 4-week interval between V1/Screening and V5/Week 24, then by each visit between V5/Week 24 to V12/Week 76 All regions: Change in Fib-4 score From baseline to week 72 All regions: Change in pediatric end-stage liver disease (PELD)/model for end-stage liver disease (MELD) score From baseline to week 72 All regions: Change in use of antipruritic medication From baseline to weeks 24, 48, and 72
Trial Locations
- Locations (41)
Children's Hospital Los Angeles
๐บ๐ธLos Angeles, California, United States
Emory University School of Medicine
๐บ๐ธAtlanta, Georgia, United States
Johns Hopkins School of Medicine
๐บ๐ธBaltimore, Maryland, United States
Children's Hospital of Philadelphia
๐บ๐ธPhiladelphia, Pennsylvania, United States
Children's Hospital of Pittsburgh
๐บ๐ธPittsburgh, Pennsylvania, United States
Akdeniz University
๐น๐ทAntalya, Turkey
Riley Hospital for Children - Riley Children's Specialists
๐บ๐ธIndianapolis, Indiana, United States
Icahn School of Medicine at Mount Sinai
๐บ๐ธNew York, New York, United States
Columbia University Medical Center - Presbyterian Hospital Building
๐บ๐ธNew York, New York, United States
Cliniques Universitaires Saint-Luc
๐ง๐ชWoluwe-Saint-Lambert, Belgium
Baylor College of Medicine - Texas Children's Liver Center
๐บ๐ธHouston, Texas, United States
The Royal Children's Hospital
๐ฆ๐บMelbourne, Australia
University and Pediatric Hospital of Lyon
๐ซ๐ทBron, France
Universite Paris SUD - Hpitaux Universitaires Paris-Sud - Hopital Bicetre
๐ซ๐ทLe Kremlin-Bicรชtre, France
Hospital De La Timone
๐ซ๐ทMarseille, France
Hospital Necker-Enfants Maladies
๐ซ๐ทParis, France
Medizinische Hochschule Hannover
๐ฉ๐ชHannover, Germany
Kinderklinik Tubingen, Universitatsklinikum Tubingen
๐ฉ๐ชTรผbingen, Germany
Univesitatsklinikum Tubingen Klinik fur Kinder und Jugendmedizin
๐ฉ๐ชTรผbingen, Germany
University Medical Center Groningen
๐ณ๐ฑGroningen, Netherlands
King Faisal Specialist Hospital & Research Centre
๐ธ๐ฆRiyadh, Saudi Arabia
Hospital Universitari Vall d'Hebron
๐ช๐ธBarcelona, Spain
Instytut Pomnik - Centrum Zarowia Dziecka
๐ต๐ฑWarsaw, Poland
Hospital Universitario La Paz
๐ช๐ธMadrid, Spain
Astrid Lindgren Children's Hospital, Karolinska University Hospital
๐ธ๐ชSolna, Sweden
Gazi University
๐น๐ทAnkara, Turkey
Hacettepe University Faculty of Medicine
๐น๐ทAnkara, Turkey
Istanbul University Medical Faculty
๐น๐ทIstanbul, Turkey
Inonu University Medical Faculty
๐น๐ทMalatya, Turkey
Leeds General Infirmary
๐ฌ๐งLeeds, United Kingdom
Birmingham Women's and Children's NHS Foundation Trust
๐ฌ๐งBirmingham, United Kingdom
Institute of Liver Studies - Kings College Hospital
๐ฌ๐งLondon, United Kingdom
Universitair Medisch Centrum (UMC) Utrecht
๐ณ๐ฑUtrecht, Netherlands
Schneider Children's Medical Center Of Israel
๐ฎ๐ฑPetach-Tikva, Israel
Shaare-Zedek Mc
๐ฎ๐ฑJerusalem, Israel
Azienda Ospedaliera Papa Giovanni XXIII
๐ฎ๐นBergamo, Italy
University Hospital Of Padova
๐ฎ๐นPadova, Italy
Ospedale Regina Margherita
๐ฎ๐นTorino, Italy
Children's Hospital Colorado
๐บ๐ธDenver, Colorado, United States
The Hospital for Sick Children
๐จ๐ฆToronto, Canada
Washington University School of Medicine
๐บ๐ธSaint Louis, Missouri, United States